We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+37.81%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$4.66B
AUM Growth
+$539M
Cap. Flow
-$225M
Cap. Flow %
-4.83%
Top 10 Hldgs %
41.2%
Holding
160
New
26
Increased
26
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$372M
2
KRON
Kronos Bio
KRON
+$41.3M
3
SQZ
SQZ Biotechnologies Company
SQZ
+$41M
4
Z icon
Zillow
Z
+$38.7M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$37.2M

Top Sells

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$71.8M
2
BABA icon
Alibaba
BABA
+$62.5M
3
MRNA icon
Moderna
MRNA
+$25.3M
4
STNE icon
StoneCo
STNE
+$21.2M
5
SRRK icon
Scholar Rock
SRRK
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 77.21%
2 Consumer Discretionary 9.12%
3 Technology 2.01%
4 Communication Services 1.85%
5 Real Estate 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
151
Regenxbio
RGNX
$626M
– –
-222,300
Closed -$6.12M
RPRX icon
152
Royalty Pharma
RPRX
$26.4B
– –
-250,000
Closed -$10.5M
SLDB icon
153
Solid Biosciences
SLDB
$817M
– –
-114,000
Closed -$3.47M
STNE icon
154
StoneCo
STNE
$2.69B
– –
-400,000
Closed -$21.2M
VXRT
155
DELISTED
Vaxart
VXRT
– –
-750,000
Closed -$4.99M
XLI icon
156
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
– –
-500,000
Closed -$38.5M
ZNTL icon
157
Zentalis Pharmaceuticals
ZNTL
$332M
– –
-87,400
Closed -$2.86M
EPZM
158
DELISTED
Epizyme, Inc
EPZM
– –
-1,000,000
Closed -$11.9M
PAND
159
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-145,000
Closed -$1.66M
PRVL
160
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-302,750
Closed -$3.08M
3 4 5 6
7

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q4 2020 Portfolio in Review

As of Q4 2020, Artal Group held 160 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Artal Group withdrew a net $225M in Q4 2020, closing 30 positions and reducing 23 holdings. Its most notable exit was StoneCo, an estimated $21.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 57% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Artal Group opened a new position in Seer Inc worth $328M.

  • Artal Group's largest Q4 2020 buy was Seer Inc: 5,840,911 shares worth $328M.
  • Artal Group added most to Zillow in Q4 2020, an estimated $38.7M increase.
  • Artal Group's biggest Q4 2020 reduction was BioNTech, cutting an estimated $71.8M.
  • Artal Group fully exited StoneCo in Q4 2020, selling an estimated $21.2M.
  • Artal Group's ten largest holdings make up 41% of its $4.66B portfolio in Q4 2020.
  • Artal Group opened 26 new positions and closed 30 in Q4 2020.
  • Artal Group's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Artal Group's 13F filing for Q4 2020, filed 11 Feb 2021.